Mold-Tek Packaging Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/s90yv9pn48a45oyqg83v96ao.pdf

Key Takeaways


Volume Growth & the Quarter’s Miss

Lakshmana Rao: "In fact the demand is still better. We could have easily posted a 15% volume growth had we got the spares and support in time, but unfortunately worldwide there is a shortage of semiconductors and electronic parts, spare parts or maintenance parts and supply of printing machines not come in as expected by us."

Segment Mix Shift

SegmentValue Share (Q2 FY22)Value Share (Q2 FY23)YoY GrowthCommentary
Paints59.0%53.8%▲ 4%Extended monsoon hurt offtake; Asian Paints increased credit terms.
Lubes19.3%22.0%▲ 26%Driven by IML conversion wins with Valvoline, Benzol and other private majors; DEF product growth continued.
Food & FMCG21.4%24.1%▲ strongGaining share; new Daman and Panipat plants being built primarily for this segment.

Cost Headwinds & Margin Pressure


Capacity Build-Out & Plant Pipeline

Lakshmana Rao: "See as I told you we are very careful in our assessment for setting up any new plants and we are also have a plan B like producing our food and FMCG products in that region... we are prudent in our investments and we will have other products also other than just paints to make sure that our investments reap good benefits."

Pharma & IBM: The Next Margin Driver

Lakshmana Rao: "With the addition of Pharma in the year 2023-2024 to a very small extent but from 2024 to 2025 in a decent manner we will be in a position to ramp up the EBITDA numbers towards 45 levels so as I indicated last quarter also in a couple of years we can look at EBITDA in the region of 45."

Dispenser Pumps: Acknowledged Disappointment

Lakshmana Rao: "Yes I agree and admit that the dispenser pumps our business is not at par with what we anticipated... So having identified that this could be an area of not so great performance in future we are holding for a couple of varieties of pumps what we invested on and trying to break even and recover our costs of the investment."

Guidance & Commitments

CommitmentSpecificsTimeline
FY23 volume growthVery close to 20% (first time in company history exceeding 15%)FY23, barring drastic economic events
FY24 volume growth15% definitely possible; very close to 20% if Pharma picks up a little, Panipat starts some production, and Daman adds Asian clientsFY24
In-house label printing capacityTwo new machines by end-Nov/mid-Dec 2022; sixth machine by Jan-end if trials succeed; stops outside label purchasesBy January 2023
OPM benefit from in-house labels~₹3–4 Cr per annum savings, improving marginsFrom January 2023 onward
OTC product (IBM) commercial startOrder value ~₹7–8 Cr per annumJanuary–February 2023
Pharma IBM commercial trialsTrials begin; client approvals take 3–6 months eachApril–May 2023
Pharma commercial invoicingMeaningful numbersFrom mid-FY24; material only in FY2024-25
Panipat plant commercialsPlant operational, numbers stabilizeOctober 2023; FY2024-25
Daman plant (food & FMCG)Construction start, completion within six monthsMay–June 2023 start
EBITDA marginRamp toward 45 levelsIn a couple of years (FY25–FY26 timeframe)
Next 3 years volume growth15–20% rangeFY23–FY25
Power cost pass-through70–80% of clients approve in 3–4 months; remaining 20–30% in 6 months to 1 yearOngoing
QR code commercializationHoping one player (Valvoline/Castrol) startsThis quarter or by end of calendar year 2022

Key Metrics

MetricQ2 FY23
Volume growth11% YoY
Revenue growth (rupee terms)14.4% YoY
PAT growth10.5% YoY
EBITDA~₹41 cr, would have been 42–43 cr without label and power cost impacts
IML and labeled containers volume share62.5%, up from 58.7% in Q2 FY22
IML and labeled containers value share66.6%, up from 62.3% in Q2 FY22
Paints segment value share53.8%, down from 59% in Q2 FY22
Lubes segment value share22%, up from 19.3% in Q2 FY22
Food and FMCG segment value share24.1%, up from 21.4% in Q2 FY22
Paints volume4,850 tonnes, grew 4% YoY
Lubes volume~2,000 tonnes, grew 26% YoY; sequential decline from over 2,600 tonnes in Q1 FY23
Food and FMCG volume1,520 tonnes
Lubes revenue₹40 cr, down ~25% sequentially from ₹55 cr in Q1 FY23
H1 FY23 sales~₹400 cr
Debtors₹159 cr in H1 FY23, up from ₹143 cr in FY22 and ~₹90 cr in FY21
Raw material price₹105–110, stabilizing after hitting ₹140 in Feb–Mar FY22
FY23 volume growth target15–20%, confident of reaching close to 20%
FY24 volume growth outlook15% minimum, could approach 20% if Pharma and Panipat contribute
Total capacity addition planned (FY23–FY24)24,000–25,000 tonnes
ABG Panipat plant expected volume (year two)1,500–2,000 tonnes, commercials from Oct 2023
Dispenser pump capacity0.5–0.6 cr pumps per annum; current volumes below 0.1 cr per month
Lost sales due to IML label shortage3–4% of sales in Q2
Additional cost from outside label procurement₹1–1.5 cr
In-house label making savings expected₹3–4 cr per annum at OPM level once capacities created by Jan
Power cost increase12–15% across Telangana, Andhra, Daman; contributed ~1% to overall cost increase
Internal accruals (net of dividend)₹90–100 cr
Debt-equity ratioless than 0.1, including working capital debt
Annual investment capacity₹100–120 cr from internal accruals and debt